FDA approves new single tablet HIV treatment
The FDA yesterday approved Bristol-Myers Squibb’s and Gilead Sciences Atripla, the first ever once-a-day single tablet regiment to treat HIV ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.